|
2026 Journal Article A systematic review and meta-analysis of the global epidemiology of carbapenem-resistant Escherichia coliWalker, Mikaela M., Li, Yixuan, Roberts, Jason A. and Sime, Fekade B. (2026). A systematic review and meta-analysis of the global epidemiology of carbapenem-resistant Escherichia coli. International Journal of Antimicrobial Agents, 67 (1) 107668, 1-8. doi: 10.1016/j.ijantimicag.2025.107668 |
|
2026 Journal Article An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoringFresán, Daniel, Sorlí, Luisa, Barceló-Vidal, Jaume, Rodrigo-Moreno, Ana, Muñoz, Rosana, Subirana, Isaac, Ferrer, Antoni, Velasco, Camila, Roberts, Jason, Benítez-Cano, Adela and Luque, Sonia (2026). An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring. International Journal of Antimicrobial Agents, 67 (1) 107661, 107661. doi: 10.1016/j.ijantimicag.2025.107661 |
|
2025 Journal Article Antibacterial pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation (ECMO): a systematic review of population pharmacokinetic studiesRen, Chanelle, Huang, Frank, Cheng, Vesa, Xie, Jiao, Roberts, Jason A and Abdul-Aziz, Mohd H (2025). Antibacterial pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation (ECMO): a systematic review of population pharmacokinetic studies. Clinical pharmacokinetics. doi: 10.1007/s40262-025-01596-z |
|
2025 Journal Article Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic reviewCoste, Anne, Aubron, Cécile, Ansart, Séverine, Roberts, Jason, Morio, Florent and Grégoire, Matthieu (2025). Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review. Critical Care. doi: 10.1186/s13054-025-05697-w |
|
2025 Journal Article Convalescent plasma in hospitalised patients with COVID-19Mcquilten, Zoe, O'sullivan, Matthew V. N., Purcell, Damien, Edler, Peta, Meagher, Niamh, Alcorn, Kylie, Bowen, Asha, Daly, James, Foo, Hong, Goulding, Susan, Gosbell, Iain, Hammond, Naomi, Hills, Thomas, Hoad, Veronica, Jha, Vivekanand, Lim, Lyn Li, Mcphee, Grace, Molton, James, Morpeth, Susan, Nguyen, Vi, Paterson, David, Rees, Megan, Roberts, Jason, Rogers, Benjamin A., Stewart, Adam, Sasadeusz, Joe, Snelling, Thomas, Venkatesh, Balasubramanian, Wood, Erica ... Denholm, Justin T. (2025). Convalescent plasma in hospitalised patients with COVID-19. Internal Medicine Journal, 55 (12) imj.70253, 2024-2032. doi: 10.1111/imj.70253 |
|
2025 Journal Article The impact of an ex vivo pediatric extracorporeal membrane oxygenation circuit on sequestration of antimicrobialsCree, Michele L., Abdul-Aziz, Mohd Hafiz, Haisz, Emma, Wallis, Steven C., Won, Hayoung, Sumi, Chandra D., Marjanovic, Dusan, Ordóñez, Jenny L., Schlapbach, Luregn J. and Roberts, Jason A. (2025). The impact of an ex vivo pediatric extracorporeal membrane oxygenation circuit on sequestration of antimicrobials. Critical Care Explorations, 7 (11) e1338, e1338. doi: 10.1097/CCE.0000000000001338 |
|
2025 Journal Article Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutionsJarrett, Paul, Coyer, Fiona M., Long, Debbie, Roberts, Jason A. and Keogh, Samantha (2025). Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions. Australian Critical Care, 38 (6) 101450, 101450-6. doi: 10.1016/j.aucc.2025.101450 |
|
2025 Journal Article Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairmentSulaiman, Helmi, Rozali, Muhammad Azrai, Adiraju, Santosh K. S., Hasan, M. Shahnaz, Jamal, Janattul A., Liu, Xin, Mat-Nor, Mohd-Basri, Mazlan, Mohd Zulfakar, Othman-Jailani, Mohamad Irfan, Salmuna, Zeti Norfidiyati, Wallis, Steven C., Roberts, Jason A. and Abdul-Aziz, Mohd H. (2025). Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment. Scientific Reports, 15 (1) 37781, 1-12. doi: 10.1038/s41598-025-20630-5 |
|
2025 Journal Article Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgeryCheng, Vesa, Suna, Jessica, Liu, Xin, Moloney, Gregory, Marathe, Supreet P., Parker, Suzanne, Ungerer, Jacobus P. J., McWhinney, Brett, Venugopal, Prem, Alphonso, Nelson and Roberts, Jason A. (2025). Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery. Anaesthesia, critical care & pain medicine 101653, 101653. doi: 10.1016/j.accpm.2025.101653 |
|
2025 Journal Article Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infectionsBenavent, Eva, Lora-Tamayo, Jaime, Ulldemolins, Marta, Pons-Oltra, Paula, Gregoire, Matthieu, Mancheno-Losa, Mikel, Hernandez-Jimenez, Pilar, Melendez-Carmona, M. Angeles, Casals, Victor, Roberts, Jason A., Rigo-Bonnin, Raul and Murillo, Oscar (2025). Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections. Antimicrobial Agents and Chemotherapy, 69 (12) e00773-25, e0077325. doi: 10.1128/aac.00773-25 |
|
2025 Journal Article Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidenceMohammed, Solomon Ahmed, Roberts, Natasha, Nicolás, David, Unwin, Sean, Cotta, Menino, Roberts, Jason A. and Sime, Fekade B. (2025). Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidence. Journal of Infection and Public Health, 18 (10) 102938, 102938. doi: 10.1016/j.jiph.2025.102938 |
|
2025 Journal Article Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjectsHernandez-Mitre, Maria Patricia, Wallis, Steven C., Loutit, Jeffery S., Griffith, David C. and Roberts, Jason A. (2025). Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects. Antimicrobial Agents and Chemotherapy, 69 (10) e00784-25, e0078425. doi: 10.1128/aac.00784-25 |
|
2025 Journal Article Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialJong, Tiffany, Baird, Timothy, Barr, Helen Louise, Bell, Scott, Bigirumurame, Theophile, Brady, Kara, Burke, Andrew, Byrnes, Joshua, Caudri, Daan, Clark, Julia E., Coin, Lachlan J.M., Goh, Felicia, Grimwood, Keith, Hicks, Daniel, Jayawardana, Kaushala, Joshi, Sri, Lee, Katherine, Qvist, Tavs, Reid, David, Rice, Megan, Roberts, Jason A., Rogers, Geraint, Shackleton, Claire, Sly, Peter D., Smyth, Alan R., Stevens, Luke, Stockwell, Rebecca, Tarique, Abdullah, Taylor, Steven ... Wainwright, Claire (2025). Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial. BMJ Open, 15 (9) e096188, 1-16. doi: 10.1136/bmjopen-2024-096188 |
|
2025 Journal Article Optimization of antimicrobial therapy in critically ill patients, What Clinicians and Searchers Must KnowRoger, Claire, Koulenti, Despoina, Novy, Emmanuel, Roberts, Jason and Dahyot-Fizelier, Claire (2025). Optimization of antimicrobial therapy in critically ill patients, What Clinicians and Searchers Must Know. Anaesthesia Critical Care and Pain Medicine, 44 (5) 101561, 1-6. doi: 10.1016/j.accpm.2025.101561 |
|
2025 Journal Article International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challengeMitri, Elise A., Fletcher, Luke R., Paynter, Camille, Vogrin, Sara, James, Fiona, Ng, Irvin, Holmes, Natasha E., Ierano, Courtney, Roberts, Jason A., Fernando, Suran L., Klaic, Marlena and Trubiano, Jason A. (2025). International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge. PLOS ONE, 20 (9 September) e0330724, e0330724. doi: 10.1371/journal.pone.0330724 |
|
2025 Journal Article Antibiotic therapy for severe bacterial infectionsTimsit, Jean-Francois, Ling, Lowell, de Montmollin, Etienne, Bracht, Hendrik, Conway-Morris, Andrew, De Bus, Liesbet, Falcone, Marco, Harris, Patrick N. A., Machado, Flavia R., Paiva, Jose-Artur, Paterson, David L., Poulakou, Garyphallia, Roberts, Jason A., Roger, Claire, Shorr, Andrew F., Tabah, Alexis and Lipman, Jeffrey (2025). Antibiotic therapy for severe bacterial infections. Intensive Care Medicine, 51 (10), 1867-1885. doi: 10.1007/s00134-025-08063-0 |
|
2025 Journal Article Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trialsLi, Yixuan, Roberts, Jason A., Abdul-Aziz, Mohd H. and Sime, Fekade B. (2025). Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials. Antimicrobial Agents and Chemotherapy, 69 (10) e0073225, 1-13. doi: 10.1128/aac.00732-25 |
|
2025 Journal Article Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteriaZaghi, Irene, Cricca, Monica, Roberts, Jason A., Brandolini, Martina, Colosimo, Claudia, Montanari, Sofia, Sambri, Vittorio and Lewis, Russell E. (2025). Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteria. Journal of Antimicrobial Chemotherapy, 80 (10), 2705-2713. doi: 10.1093/jac/dkaf276 |
|
2025 Journal Article Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapyRoberts, Jason A., Ulldemolins, Marta, Liu, Xin, Baptista, João P., Bilgrami, Irma, Boidin, Clement, Brinkmann, Alexander, Castro, Pedro, Choi, Gordon, Cole, Louise, De Waele, Jan J., Deans, Renae, Donnellan, Sine, Eastwood, Glenn M., Frey, Otto R., Goutelle, Sylvain, Gresham, Rebecca, Jamal, Janattul Ain, Joynt, Gavin M., Kanji, Salmaan, Kluge, Stefan, König, Christina, Koulouras, Vasilios P., Lassig-Smith, Melissa, Laterre, Pierre-Francois, Lee, Anna, Lefrant, Jean-Yves, Lei, Katie, Leung, Patricia ... Young, Helen (2025). Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy. Intensive Care Medicine, 51 (9), 1628-1640. doi: 10.1007/s00134-025-08067-w |
|
2025 Journal Article The changing epidemiology of Candida species in Asia Pacific and evidence for optimizing antifungal dosing in challenging clinical scenariosChen, Yee-Chun, Dhillon, Sohita, Adomakoh, Nicholas and Roberts, Jason A. (2025). The changing epidemiology of Candida species in Asia Pacific and evidence for optimizing antifungal dosing in challenging clinical scenarios. Expert Review of Anti-Infective Therapy, 23 (10), 969-983. doi: 10.1080/14787210.2025.2539427 |
